News

NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the "Company"), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic ...
Island Pharmaceuticals hopes the FDA will approve its acquired asset Galidesivir on the back of animal testing alone. ...